Reactions 1680, p14 - 2 Dec 2017 Transient renal dysfunction: case report A 12-year-old boy developed transient renal dysfunction during treatment with aciclovir [acyclovir]. The boy, who developed small papules and blisters on the left side of his face, severe headache and hyperaemia of the left bulbar conjunctiva, was started on treatment with IV acyclovir 31 mg/kg/day. The symptoms did not resolve after 4 days of aciclovir treatment and he vomited repeatedly. From a PCR, he was eventually diagnosed with Herpes zoster meningitis and his aciclovir dose was increased to 53 mg/kg/day. Subsequently, his symptoms improved. Five days later, his serum creatinine increased from 0.57 mg/dL to 0.88 mg/dL. The dose of aciclovir was reduced back to 31 mg/kg/day and the serum creatinine improved to 0.55 mg/dL. The changes in serum creatinine were suggestive of transient renal dysfunction. Author comment: "We should consider increasing the [aciclovir] dosage to the maximum dose, while monitoring for drug induced renal disorder, even in healthy children." Itoh N, et al. Herpes zoster meningitis in immunocompetent children: Two case reports and a literature review. Pediatrics International 59: 1116-1118, No. 10, Oct 2017. Available from: URL: http://doi.org/10.1111/ped.13362 - Japan 803284324 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera